🇺🇸 FDA
Patent

US 10035761

Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives

granted A61PA61P25/24A61P3/04

Quick answer

US patent 10035761 (Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives) held by REVIVA PHARMACEUTICALS, INC. expires Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REVIVA PHARMACEUTICALS, INC.
Grant date
Tue Jul 31 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61P, A61P25/24, A61P3/04